Skip to main content
Clinical Trials/CTRI/2021/09/036128
CTRI/2021/09/036128
Not yet recruiting
未知

Establishment and Validation of Urine Biomarkers before Prostate Biopsy: A Sequential-Enrollment, Blinded Study

Medicametrix0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Medicametrix
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Medicametrix

Eligibility Criteria

Inclusion Criteria

  • Cohort randomized prospective study, signed informed consent, Male between age 45 AND 85 suspected case of prostate cancer (PCa) before biospy, Total PSA \& Free PSA, 4K Score/PHI, Prostate volume, Testoterone, Routine urine analysis, Biochemical test, transrectal ultrasound (TRUS)\-guided biopsies or DRE, MR Scan, microscopic anatomy, Gleason Score and estimates the overall â??Cancer Aggressivenessâ?? Score Sandwich Elisa.

Exclusion Criteria

  • Patients come for second and third opinions, Unable to perform a Rectal Examination or any reason, Certain Lower Urinary Tract Congenital Abnormalities inability to understand or give informed consent, Patients with history of HIV, HBV, TB.

Outcomes

Primary Outcomes

Not specified

Similar Trials